163 related articles for article (PubMed ID: 36473425)
61. Assessing whether early attention of very preterm infants can be improved by an omega-3 long-chain polyunsaturated fatty acid intervention: a follow-up of a randomised controlled trial.
Gould JF; Colombo J; Collins CT; Makrides M; Hewawasam E; Smithers LG
BMJ Open; 2018 May; 8(5):e020043. PubMed ID: 29804059
[TBL] [Abstract][Full Text] [Related]
62. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia.
Carlson SE; Werkman SH; Tolley EA
Am J Clin Nutr; 1996 May; 63(5):687-97. PubMed ID: 8615350
[TBL] [Abstract][Full Text] [Related]
63. Postnatal RBC arachidonic and docosahexaenoic acids deficiencies are associated with higher risk of neonatal morbidities and mortality in preterm infants.
Fares S; Sethom MM; Hammami MB; Cheour M; Feki M; Hadj-Taieb S; Kacem S
Prostaglandins Leukot Essent Fatty Acids; 2017 Nov; 126():112-116. PubMed ID: 29031388
[TBL] [Abstract][Full Text] [Related]
64. Prophylactic Sildenafil in Preterm Infants at Risk of Bronchopulmonary Dysplasia: A Pilot Randomized, Double-Blinded, Placebo-Controlled Trial.
Abounahia FF; Abu-Jarir R; Abounahia MF; Al-Badriyeh D; Abushanab D; Abu-Ghalwa M; Mansour A; Kurdi B; Al-Rifai H
Clin Drug Investig; 2019 Nov; 39(11):1093-1107. PubMed ID: 31414269
[TBL] [Abstract][Full Text] [Related]
65. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial.
Makrides M; Gibson RA; McPhee AJ; Collins CT; Davis PG; Doyle LW; Simmer K; Colditz PB; Morris S; Smithers LG; Willson K; Ryan P
JAMA; 2009 Jan; 301(2):175-82. PubMed ID: 19141765
[TBL] [Abstract][Full Text] [Related]
66. High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes.
Manley BJ; Makrides M; Collins CT; McPhee AJ; Gibson RA; Ryan P; Sullivan TR; Davis PG;
Pediatrics; 2011 Jul; 128(1):e71-7. PubMed ID: 21708809
[TBL] [Abstract][Full Text] [Related]
67. The effect of supplementation of docosahexaenoic acid and arachidonic acid on visual acuity and neurodevelopment in larger preterm infants.
Fang PC; Kuo HK; Huang CB; Ko TY; Chen CC; Chung MY
Chang Gung Med J; 2005 Oct; 28(10):708-15. PubMed ID: 16382755
[TBL] [Abstract][Full Text] [Related]
68. Effects of maternal docosahexaenoic acid supplementation on brain development and neurodevelopmental outcomes of breastfed preterm neonates: protocol for a follow-up at preschool age of a randomised clinical trial (MOBYDIckPS).
Guillot M; Robitaille CA; Turner L; Pronovost E; Caouette G; Matte-Gagné C; Olivier F; Bartholomew J; Massé É; Morin A; Mohamed I; Marc I
BMJ Open; 2022 May; 12(5):e057482. PubMed ID: 35508343
[TBL] [Abstract][Full Text] [Related]
69. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
70. Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
Kirpalani H; Ratcliffe SJ; Keszler M; Davis PG; Foglia EE; Te Pas A; Fernando M; Chaudhary A; Localio R; van Kaam AH; Onland W; Owen LS; Schmölzer GM; Katheria A; Hummler H; Lista G; Abbasi S; Klotz D; Simma B; Nadkarni V; Poulain FR; Donn SM; Kim HS; Park WS; Cadet C; Kong JY; Smith A; Guillen U; Liley HG; Hopper AO; Tamura M;
JAMA; 2019 Mar; 321(12):1165-1175. PubMed ID: 30912836
[TBL] [Abstract][Full Text] [Related]
71. Effects of different arachidonic acid supplementation on psychomotor development in very preterm infants; a randomized controlled trial.
Alshweki A; Muñuzuri AP; Baña AM; de Castro MJ; Andrade F; Aldamiz-Echevarría L; de Pipaón MS; Fraga JM; Couce ML
Nutr J; 2015 Sep; 14():101. PubMed ID: 26424477
[TBL] [Abstract][Full Text] [Related]
72. Antenatal Determinants of Bronchopulmonary Dysplasia and Late Respiratory Disease in Preterm Infants.
Morrow LA; Wagner BD; Ingram DA; Poindexter BB; Schibler K; Cotten CM; Dagle J; Sontag MK; Mourani PM; Abman SH
Am J Respir Crit Care Med; 2017 Aug; 196(3):364-374. PubMed ID: 28249118
[TBL] [Abstract][Full Text] [Related]
73. Plasma phospholipids indicate impaired fatty acid homeostasis in preterm infants.
Bernhard W; Raith M; Koch V; Kunze R; Maas C; Abele H; Poets CF; Franz AR
Eur J Nutr; 2014 Oct; 53(7):1533-47. PubMed ID: 24464176
[TBL] [Abstract][Full Text] [Related]
74. A dose response randomised controlled trial of docosahexaenoic acid (DHA) in preterm infants.
Collins CT; Sullivan TR; McPhee AJ; Stark MJ; Makrides M; Gibson RA
Prostaglandins Leukot Essent Fatty Acids; 2015 Aug; 99():1-6. PubMed ID: 25997653
[TBL] [Abstract][Full Text] [Related]
75. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD002311. PubMed ID: 28836266
[TBL] [Abstract][Full Text] [Related]
76. Docosahexaenoic acid-rich algae oil supplementation in mothers of preterm infants is associated with a modification in breast milk oxylipins profile.
Fougère H; Greffard K; Guillot M; Rudkowska I; Pronovost E; Simonyan D; Marc I; Bilodeau JF
Lipids Health Dis; 2023 Jul; 22(1):103. PubMed ID: 37452341
[TBL] [Abstract][Full Text] [Related]
77. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
[TBL] [Abstract][Full Text] [Related]
78. Inhaled nitric oxide for respiratory failure in preterm infants.
Barrington KJ; Finer NN
Cochrane Database Syst Rev; 2007 Jul; (3):CD000509. PubMed ID: 17636641
[TBL] [Abstract][Full Text] [Related]
79. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
[TBL] [Abstract][Full Text] [Related]
80. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid.
Henriksen C; Haugholt K; Lindgren M; Aurvåg AK; Rønnestad A; Grønn M; Solberg R; Moen A; Nakstad B; Berge RK; Smith L; Iversen PO; Drevon CA
Pediatrics; 2008 Jun; 121(6):1137-45. PubMed ID: 18519483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
